C12 Galactosylceramide (d18:1/12:0) [41613-14-3]
Referência NB-64-24552-1mg
Tamanho : 1mg
Marca : Neo Biotech
C12 Galactosylceramide (d18:1/12:0)
Catalog No. T36858 Copy Product Info
C12 Galactosylceramide is a bioactive sphingolipid. It inhibits IL-4 production by 53.84% in EL4 T cells when used at a concentration of 10 μM. C12 Galactosylceramide reduces the growth of human papillomavirus type 16-associated tumors in mice and reduces tumor recurrence following surgical removal or chemotherapy. It also reduces natural killer T cell activity, delays the onset of proteinuria, and improves survival in a mouse model of systemic lupus.
C12 Galactosylceramide (d18:1/12:0)
Copy Product InfoC12 Galactosylceramide is a bioactive sphingolipid. It inhibits IL-4 production by 53.84% in EL4 T cells when used at a concentration of 10 μM. C12 Galactosylceramide reduces the growth of human papillomavirus type 16-associated tumors in mice and reduces tumor recurrence following surgical removal or chemotherapy. It also reduces natural killer T cell activity, delays the onset of proteinuria, and improves survival in a mouse model of systemic lupus.
Cas No. 41613-14-3
Product Introduction
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | C12 Galactosylceramide is a bioactive sphingolipid. It inhibits IL-4 production by 53.84% in EL4 T cells when used at a concentration of 10 μM. C12 Galactosylceramide reduces the growth of human papillomavirus type 16-associated tumors in mice and reduces tumor recurrence following surgical removal or chemotherapy. It also reduces natural killer T cell activity, delays the onset of proteinuria, and improves survival in a mouse model of systemic lupus. |
| Molecular Weight | 643.947 |
| Formula | C36H69NO8 |
| Cas No. | 41613-14-3 |
| Smiles | CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCC |
| Storage | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | Ethanol: Soluble Methanol: Soluble |